The Effect of Hippotherapy Simulator in Cerebral Palsy

NCT ID: NCT05518370

Last Updated: 2024-05-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-08-26

Study Completion Date

2023-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hippotherapy simulators imitate the passive movements of the horse, producing simple movements similar to those of the horse. Hippotherapy simulators are intended to improve sitting balance, postural control and trunk balance.

The aim of this study was to research the therapeutic effects of hippotherapy simulator on sitting balance, trunk control and upper extremity skills in individuals with Cerebral Palsy (CP).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Spastic CP will be participate the study between the ages of 4 and 18 years. Children's classified with GMFCS and MACS.

The eligible participants will be allocated two groups, including hippotherapy simulator training group and traditional physiotherapy control group. All the assessments will be performed before and after the training in the 8-week training groups.

The control group individuals will be given a traditional physiotherapy two days per week for a total of 8 weeks (traditional physiotherapy session will last 45 minutes). Hippotherapy simulator training group will receive a traditional physiotherapy and hippotherapy simulator training, two days a week for a total of 8 weeks (30 minutes traditional physiotherapy session+15 minutes hippotherapy simulator training). All sessions will be performed in the clinic with the specialist physiotherapist.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hippotherapy simulator training group

Hippotherapy simulator training group will receive a traditional physiotherapy and hippotherapy simulator training, two days a week for a total of 8 weeks (30 minutes traditional physiotherapy session+15 minutes hippotherapy simulator training).

Group Type EXPERIMENTAL

Hippotherapy simulator training

Intervention Type OTHER

Hippotherapy simulator training will be designed for the individual basis.

Traditional physiotherapy

Intervention Type OTHER

Traditional physiotherapy within a specific program

Traditional physiotherapy group

Traditional physiotherapy group individuals will be given a traditional physiotherapy two days per week for a total of 8 weeks (traditional physiotherapy session will last 45 minutes).

Group Type ACTIVE_COMPARATOR

Traditional physiotherapy

Intervention Type OTHER

Traditional physiotherapy within a specific program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hippotherapy simulator training

Hippotherapy simulator training will be designed for the individual basis.

Intervention Type OTHER

Traditional physiotherapy

Traditional physiotherapy within a specific program

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of Spastic Cerebral Palsy voluntary participation
* Age between 4-18 years,
* GMFCS Level I-II-III
* MACS Level I-II-III
* Have the ability to sit upright with support

Exclusion Criteria

* Not voluntary to participate in the research,
* Botox in the last 6 months
* Hip or spine surgeries in the last 6 months
Minimum Eligible Age

4 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Gaziantep Islam Science and Technology University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Demet GÖZAÇAN KARABULUT

Assistant Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Demet GÖZAÇAN KARABULUT

Role: STUDY_DIRECTOR

Gaziantep Islam Science and Technology University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziantep

Gaziantep, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

References

Explore related publications, articles, or registry entries linked to this study.

Gozacan Karabulut D, Numanoglu Akbas A. The effect of horse riding simulator on upper extremity skills, trunk control and functionality in cerebral palsy: a randomized controlled trial. Disabil Rehabil. 2025 Apr;47(7):1725-1732. doi: 10.1080/09638288.2024.2380785. Epub 2024 Jul 18.

Reference Type DERIVED
PMID: 39022889 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GIBTU-FTR-DGK-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.